Patient characteristics for the Gorlin M0 Cohort (all genetically diagnosed PTCH1 and SUFU associated Gorlin syndrome patients) vs. the Comparative M0 Cohort (all medulloblastomas (MB), SHH+, M0, <4y). The gene discussed is SUFU; the disease is nevoid basal cell carcinoma syndrome.